[新聞] Novavax COVID-19 vaccine receives first emergency use authorization

看板Stock (股票)作者Tohkachan (空白)時間4年前 (2021/11/01 23:15)推噓3(3推 0噓 14→)

留言17則, 6人參與討論串1/1

原文標題： Novavax COVID-19 vaccine receives first emergency use authorization 原文連結： https://reurl.cc/q1pel0 發布時間： November 1, 2021 8:53 PM 原文內容： Nov 1 (Reuters) - Novavax IncNVAX.O)nd partner Serum Institute of India said o n Shares of Novavax rose about 11% before the opening bell after the company als o For Indonesia, the shot will be manufactured by the world's largest vaccine ma nu Novavax said initial shipments into Indonesia are expected to begin imminently . The country is slated to receive 20 million doses of the protein-based vaccine t Penny Lukito, chief of the National Agency for Drug and Food Control of Indone si Novavax has so far applied for EUA in various countries, including the UK, Aus tr The company, along with Japanese partner Takeda Pharmaceutical Co4502.T), said o Novavax and Serum Institute have committed to together provide more than 1.1 b il Novavax has delayed filing for U.S. approval to the end of this year, and Poli ti The Novavax shot was shown to be more than 90% effective, including against a va Reporting by Dania Nadeem, Leroy Leo in Bengaluru and Stanley Widianto in Jaka rt 心得/評論： Novavax 終於在印度尼西亞迎來了第一個批准今日也提交完成歐盟及加拿大EUA ----- Sent from JPTT on my Samsung SM-G9810. -- ※ 發信站: 批踢踢實業坊(ptt.cc), 來自: 124.109.120.11 (臺灣) ※ 文章網址: https://www.ptt.cc/bbs/Stock/M.1635779748.A.7C7.html ※ 編輯: Tohkachan (124.109.120.11 臺灣), 11/01/2021 23:16:19

→

aegis43210

11/01 23:17, 4年前 , 1^F

11/01 23:17, 1^F

※ 編輯: Tohkachan (124.109.120.11 臺灣), 11/01/2021 23:19:16

→

ben745018

11/01 23:21, 4年前 , 2^F

11/01 23:21, 2^F

→

SRadiant

11/01 23:27, 4年前 , 3^F

11/01 23:27, 3^F

→

SRadiant

11/01 23:28, 4年前 , 4^F

11/01 23:28, 4^F

確實每個國家的EUA要求都不同目前看來製造問題沒有完全解決主要可能出在 Fujifilm 的德州工廠但其他合作伙伴包含韓國SKB財報表示已經從6月開始完成4000萬劑的韓國訂單將簽署新的合約來進行生產，日本武田也在股東會表示已經開始生產2.5E劑疫苗預估202 2年初獲得日本批准還有波蘭Mabion 印度SII都表示沒問題應該只有少數廠出現了問題